These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27732810)

  • 1. Modulating Immunity to Treat Autoimmune Disease.
    Amagai M
    N Engl J Med; 2016 Oct; 375(15):1487-1489. PubMed ID: 27732810
    [No Abstract]   [Full Text] [Related]  

  • 2. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.
    Ellebrecht CT; Bhoj VG; Nace A; Choi EJ; Mao X; Cho MJ; Di Zenzo G; Lanzavecchia A; Seykora JT; Cotsarelis G; Milone MC; Payne AS
    Science; 2016 Jul; 353(6295):179-84. PubMed ID: 27365313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMMUNOLOGY. Fighting autoimmunity with immune cells.
    Leslie M
    Science; 2016 Jul; 353(6294):14. PubMed ID: 27365430
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris.
    Amber KT; Staropoli P; Shiman MI; Elgart GW; Hertl M
    Exp Dermatol; 2013 Nov; 22(11):699-704. PubMed ID: 24433179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of expression of an alternative CD20 transcript variant in circulating B cells from patients with pemphigus.
    Gamonet C; Ferrand C; Colliou N; Musette P; Joly P; Girardin M; Humbert P; Aubin F
    Exp Dermatol; 2014 Jan; 23(1):66-7. PubMed ID: 24313590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of immune system effector function by T-cell or Fc receptor intracellular domains.
    Romeo C; Kolanus W; Amiot M; Seed B
    Cold Spring Harb Symp Quant Biol; 1992; 57():117-25. PubMed ID: 1339650
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab immunotherapy in pemphigus: therapeutic effects beyond B-cell depletion.
    Zambruno G; Borradori L
    J Invest Dermatol; 2008 Dec; 128(12):2745-7. PubMed ID: 18997839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into autoimmunity: from classical models to current perspectives.
    Gutierrez-Ramos JC; Andreu JL; Moreno de Alboran I; Rodriguez J; Leonardo E; Kroemer G; Marcos MA; Martinez C
    Immunol Rev; 1990 Dec; 118():73-101. PubMed ID: 2079329
    [No Abstract]   [Full Text] [Related]  

  • 9. Visualizing T-cell recognition.
    Davis MM; Wülfing C; Krummel MF; Savage PA; Xu J; Sumen C; Dustin ML; Chien YH
    Cold Spring Harb Symp Quant Biol; 1999; 64():243-51. PubMed ID: 11232292
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antigen recognition mechanism and regulation of immune responses].
    Yata J
    Nihon Rinsho; 1983; 41(4):699-704. PubMed ID: 6224947
    [No Abstract]   [Full Text] [Related]  

  • 11. Toward synthetic biology with engineered T cells: a long journey just begun.
    June CH
    Hum Gene Ther; 2014 Sep; 25(9):779-84. PubMed ID: 25244569
    [No Abstract]   [Full Text] [Related]  

  • 12. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 13. If at first you don't succeed.
    Fink PJ
    Nat Immunol; 2000 Oct; 1(4):271-2. PubMed ID: 11017092
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics of B and T cell recognition.
    Nowak JS
    Acta Anthropogenet; 1985; 9(1-3):1-19. PubMed ID: 2956972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric antigen receptor T-cell therapy to target hematologic malignancies.
    Kenderian SS; Ruella M; Gill S; Kalos M
    Cancer Res; 2014 Nov; 74(22):6383-9. PubMed ID: 25371415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why affinity progression of antibodies during immune responses is probably not accompanied by parallel changes in the immunoglobulin-like antigen-specific receptors on T cells.
    Eisen HN
    Bioessays; 1986 Jun; 4(6):269-72. PubMed ID: 3491609
    [No Abstract]   [Full Text] [Related]  

  • 17. A revival of the B cell paradigm for rheumatoid arthritis pathogenesis?
    Benoist C; Mathis D
    Arthritis Res; 2000; 2(2):90-4. PubMed ID: 11094418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with gene-modified T cells: limiting side effects provides new challenges.
    Stauss HJ; Morris EC
    Gene Ther; 2013 Nov; 20(11):1029-32. PubMed ID: 23804078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in the design of a peptide antigen specific for T cells.
    Heber-Katz E; Hollosi M; Hudecz F; Fasman G; Dietzschold B
    Ann Sclavo Collana Monogr; 1984; 1(2):119-28. PubMed ID: 6336258
    [No Abstract]   [Full Text] [Related]  

  • 20. [T and B lymphocytes in South American pemphigus foliaceus].
    Reis AP; Guerra Hde A; Guerra MV
    AMB Rev Assoc Med Bras; 1976 Aug; 22(8):285-8. PubMed ID: 1086491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.